DNAScript

DNA Script is a pioneering biotech company that has developed the SYNTAX enzymatic DNA synthesis platform, enabling researchers to produce high-quality single-stranded DNA oligos in-house overnight. Founded by Thomas Ybert and team, the company technology provides a fast, accurate, and efficient alternative to conventional chemical DNA synthesis, serving CROs, core facilities, biotech and pharma companies, and governmental agencies. Headquartered in Le Kremlin-Bicetre, France, DNA Script has raised over $324M and expanded its global distribution network.